161 related articles for article (PubMed ID: 27324961)
1. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.
Choi M; Oh J; Rhim T; Lee M
Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961
[TBL] [Abstract][Full Text] [Related]
2. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
Kim HA; Park JH; Yi N; Lee M
Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone-loaded peptide micelles for delivery of the heme oxygenase-1 gene to ischemic brain.
Lee J; Hyun H; Kim J; Ryu JH; Kim HA; Park JH; Lee M
J Control Release; 2012 Feb; 158(1):131-8. PubMed ID: 22100389
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone-Conjugated Polyamidoamine Dendrimer for Delivery of the Heme Oxygenase-1 Gene into the Ischemic Brain.
Jeon P; Choi M; Oh J; Lee M
Macromol Biosci; 2015 Jul; 15(7):1021-8. PubMed ID: 26033925
[TBL] [Abstract][Full Text] [Related]
5. Deoxycholic Acid-Conjugated Polyethylenimine for Delivery of Heme Oxygenase-1 Gene in Rat Ischemic Stroke Model.
Oh J; Lee MS; Jeong JH; Lee M
J Pharm Sci; 2017 Dec; 106(12):3524-3532. PubMed ID: 28780392
[TBL] [Abstract][Full Text] [Related]
6. Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone.
Hyun H; Lee J; Hwang DW; Kim S; Hyun DK; Choi JS; Lee JK; Lee M
Biomaterials; 2011 Jan; 32(1):306-15. PubMed ID: 20888632
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of erythropoietin enhancer-mediated hypoxia-inducible gene expression by co-transfection of a plasmid encoding hypoxia-inducible factor 1alpha for ischemic tissue targeting gene therapy.
Lee S; Kim K; Kim HA; Kim SW; Lee M
J Drug Target; 2008 Jan; 16(1):43-50. PubMed ID: 18172819
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy with an erythropoietin enhancer-mediated, hypoxia-inducible gene expression system in the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction.
Ryu JK; Lee M; Choi MJ; Kim HA; Jin HR; Kim WJ; Yin GN; Song KM; Kwon MH; Suh JK
J Androl; 2012; 33(5):845-53. PubMed ID: 22403284
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.
Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW
Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
[TBL] [Abstract][Full Text] [Related]
12. Messenger RNA/polymeric carrier nanoparticles for delivery of heme oxygenase-1 gene in the post-ischemic brain.
Oh J; Kim SM; Lee EH; Kim M; Lee Y; Ko SH; Jeong JH; Park CH; Lee M
Biomater Sci; 2020 Jun; 8(11):3063-3071. PubMed ID: 32348398
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of a reducible poly (oligo-D-arginine) carrier with the heme oxygenase-1 gene in the treatment of hypoxic-ischemic brain injury.
Hyun H; Won YW; Kim KM; Lee J; Lee M; Kim YH
Biomaterials; 2010 Dec; 31(34):9128-34. PubMed ID: 20828810
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes.
Kim H; Kim HA; Bae YM; Choi JS; Lee M
J Gene Med; 2009 Jun; 11(6):515-22. PubMed ID: 19301369
[TBL] [Abstract][Full Text] [Related]
15. Reducible Poly(Oligo-D-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model.
Kim HA; Lee HL; Choi E; Kim YH; Lee M
J Pharm Sci; 2015 Nov; 104(11):3743-3751. PubMed ID: 26178805
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia.
Kim HA; Lim S; Moon HH; Kim SW; Hwang KC; Lee M; Kim SH; Choi D
Pharm Res; 2010 Oct; 27(10):2075-84. PubMed ID: 20607367
[TBL] [Abstract][Full Text] [Related]
17. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
18. A self-assembled DNA-nanoparticle with a targeting peptide for hypoxia-inducible gene therapy of ischemic stroke.
Oh J; Lee J; Piao C; Jeong JH; Lee M
Biomater Sci; 2019 Apr; 7(5):2174-2190. PubMed ID: 30900719
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP).
Kim JM; Lee M; Kim KH; Ha Y; Choi JK; Park SR; Park H; Park HC; Ahn CH; Kim SW; Choi BH
J Control Release; 2009 Jan; 133(1):60-7. PubMed ID: 18938203
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of heme oxygenase-1 attenuates brain damage after cerebral ischemia via simultaneous inhibition of superoxide production and preservation of NO bioavailability.
Chao XD; Ma YH; Luo P; Cao L; Lau WB; Zhao BC; Han F; Liu W; Ning WD; Su N; Zhang L; Zhu J; Fei Z; Qu Y
Exp Neurol; 2013 Jan; 239():163-9. PubMed ID: 23059458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
